Saarraaken Kulenthiran
Overview
Explore the profile of Saarraaken Kulenthiran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tokcan M, Federspiel J, Lauder L, Hohl M, Al Ghorani H, Kulenthiran S, et al.
EuroIntervention
. 2024 Sep;
20(17):e1107-e1117.
PMID: 39219360
Background: A detailed understanding of the sympathetic innervation of coronary arteries is relevant to facilitate the development of novel treatment approaches. Aims: This study aimed to quantitatively examine periarterial innervation...
2.
Abdin A, Bohm M, Shahim B, Karlstrom P, Kulenthiran S, Skouri H, et al.
Int J Cardiol
. 2024 Jun;
412:132304.
PMID: 38944348
The prevalence of HF with preserved ejection raction (HFpEF, with EF ≥50%) is increasing across all populations with high rates of hospitalization and mortality, reaching up to 80% and 50%,...
3.
Abdin A, Kulenthiran S
Eur J Heart Fail
. 2024 May;
26(6):1381-1382.
PMID: 38726704
No abstract available.
4.
Al Ghorani H, Kulenthiran S, Lauder L, Recktenwald M, Dederer J, Kunz M, et al.
Clin Res Cardiol
. 2024 Mar;
113(10):1384-1392.
PMID: 38451261
Background: Randomized sham-controlled trials have confirmed the efficacy and safety of catheter-based renal denervation in hypertension. Data on the very long-term effects of renal denervation are scarce. Aims: This study...
5.
Lauder L, Perez Navarro P, Gotzinger F, Ewen S, Al Ghorani H, Haring B, et al.
Respir Res
. 2023 Oct;
24(1):257.
PMID: 37880651
Background: Mechanical thrombectomy has been shown to reduce thrombus burden and pulmonary artery pressure (PAP) and to improve right ventricular (RV) function in patients with high-risk or intermediate-high-risk pulmonary embolism...
6.
Al Ghorani H, Kulenthiran S, Recktenwald M, Lauder L, Kunz M, Gotzinger F, et al.
J Am Coll Cardiol
. 2023 Feb;
81(5):517-519.
PMID: 36725181
No abstract available.
7.
Bewarder Y, Lauder L, Kulenthiran S, Schafer O, Ukena C, Marshall R, et al.
Int J Cardiol Heart Vasc
. 2022 May;
40:101044.
PMID: 35573652
Aims: Differentiation of left ventricular (LV) hypertrophy in healthy athletes from pathological LV hypertrophy in heart disease is often difficult. We explored whether extended echocardiographic measurements such as E/e' and...
8.
Fischer P, Blumenauer D, Egger F, Fikenzer S, Zimmer A, Kulenthiran S, et al.
Am J Cardiol
. 2022 Apr;
173:1-7.
PMID: 35418332
In this randomized, prospective monocentric study, 40 subjects with coronary artery disease or hypertension (cardiovascular disease [CVD] group) were assigned to either surgical mask (SM) or class 2 filtering facepiece...
9.
Lauder L, Pereira T, Degenhardt M, Ewen S, Kulenthiran S, Coats A, et al.
Eur J Heart Fail
. 2021 Oct;
23(11):1960-1970.
PMID: 34628706
Aims: To assess the feasibility and efficacy of interatrial shunt devices (IASD) for the treatment of chronic heart failure (CHF). Methods And Results: MEDLINE and the Cochrane Central Register of...
10.
Bohm M, Tsioufis K, Kandzari D, Kario K, Weber M, Schmieder R, et al.
J Am Coll Cardiol
. 2021 Sep;
78(10):1028-1038.
PMID: 34474735
Background: Sham-controlled trials demonstrated safety and efficacy of renal denervation (RDN) to lower blood pressure (BP). Association of baseline heart rate with BP reduction after RDN is incompletely understood. Objectives:...